kabutan

SANTEN PHARMACEUTICAL CO.,LTD.(4536) Summary

4536
TSE Prime
SANTEN PHARMACEUTICAL CO.,LTD.
1,722.5
JPY
+0.5
(+0.03%)
Jan 29, 3:30 pm JST
11.26
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
16.3
PBR
2.02
Yield
2.21%
Margin Trading Ratio
18.85
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,700.0 JPY 11.10 USD
Previous Close Jan 28
1,722.0 JPY 11.28 USD
High Jan 29, 12:30 pm
1,734.0 JPY 11.32 USD
Low Jan 29, 9:00 am
1,698.0 JPY 11.09 USD
Volume
822,000
Trading Value
1.42B JPY 9.25M USD
VWAP
1720.95 JPY 11.25 USD
Minimum Trading Value
172,250 JPY 1,126 USD
Market Cap
0.56T JPY 3.65B USD
Number of Trades
2,368
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
2,582
1-Year High Aug 8, 2025
10,497
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 45,900 60,600 1.32
Jan 16, 2026 42,800 81,300 1.90
Jan 9, 2026 33,100 197,400 5.96
Dec 26, 2025 34,500 199,900 5.79
Dec 19, 2025 37,600 201,800 5.37
Company Profile
SANTEN PHARMACEUTICAL CO., LTD. is a leading manufacturer of ophthalmic pharmaceuticals. Its flagship product is the over-the-counter eye drop brand "Sante". The company is strengthening its global expansion.
Sector
Pharmaceuticals
SANTEN PHARMACEUTICAL CO., LTD. primarily focuses on prescription pharmaceuticals, while also engaging in the research, development, manufacturing, and sales of over-the-counter drugs and medical devices. The company specializes in ophthalmology products. It operates globally, with a presence in Japan, China, Asia, Europe, the Middle East, Africa, North America, and other regions worldwide, forming a global corporate group. The overseas sales ratio accounts for approximately 40% of total revenue. The group consists of SANTEN PHARMACEUTICAL CO., LTD., 34 consolidated subsidiaries, and 2 equity-method affiliates. With numerous subsidiaries across the globe, the group implements business strategies tailored to the market characteristics of each region.